Zhou Z et al. reported that Substance P promoted macrophage M2 macrophage polarization by regulating the NF-κB/NLRP3 signaling pathway, thus alleviating secondary lymphedema (Zhou et al., 2023). The gene discussed is NLRP3; the disease is lymphedema.